ASTRO holds first legislative training program in Washington, D.C.

NewsGuard 100/100 Score

Members of the American Society for Therapeutic Radiology and Oncology converged on Capitol Hill in Washington, D.C., last week for the Society’s inaugural legislative training and advocacy program. During the two-day event, 35 ASTRO members from 19 states met with more than 70 U.S. Senators, Representatives and congressional staff to promote the Society’s legislative priorities, including increased funding for cancer research, enacting patient safety legislation and correcting the fundamentally flawed Medicare Physician Fee Schedule.

Participants heard from key public policy officials and received briefings on the federal legislative and regulatory processes. ASTRO also conducted a widely attended “High-Tech High-Touch” Cancer Symposium to educate congressional health aides on the Society, the critical role of radiation oncologists in treating cancer patients and some of the new tools and techniques used by radiation oncologists to treat cancer.

“Radiation oncology is an extremely important, but often overlooked specialty,” said Prabhakar Tripuraneni, M.D., ASTRO President-elect and a radiation oncologist at Scripps Clinic in La Jolla, Calif. “I think our members did an excellent job helping educate their congressional representatives and staff members about the critical role we play in caring for patients with cancer and other diseases.”

To learn more about radiation therapy or ASTRO’s 46th Annual Meeting, scheduled for October 3-7, 2004, in Atlanta, please visit


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI model sets benchmark in digital pathology with superior cancer diagnostics